Evaluating Representativeness of Pathology Samples for Human Biomonitoring (2025-2027)
Abstract
For the first time the National Health Measures Survey (NHMS) and the Australian Health Biobank (AHB) are collecting and archiving blood and urine samples from a representative group of the population. The aim of this DP is to systematically compare the cost and time effective human biomonitoring (HBM) program which is built on pooled pathology samples since 2002, with pools produced from the NHMS/AHB samples, establish statistical distribution data and determine reference exposure values for a wide range of legacy and emerging chemical pollutants. This DP will result in a more robust HBM program, adding value to past, current, and future HBM data to result in a world class method that is representative of general population exposure.
